Acutus Medical (AFIB) Competitors $0.03 +0.00 (+3.90%) As of 03:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock AFIB vs. NUWE, VERO, CHEK, GCTK, HSCS, QNRX, CTCX, TTOO, BBLG, and TIVCShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Nuwellis (NUWE), Venus Concept (VERO), Check-Cap (CHEK), GlucoTrack (GCTK), Heart Test Laboratories (HSCS), Quoin Pharmaceuticals (QNRX), Carmell (CTCX), T2 Biosystems (TTOO), Bone Biologics (BBLG), and Tivic Health Systems (TIVC). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Nuwellis Venus Concept Check-Cap GlucoTrack Heart Test Laboratories Quoin Pharmaceuticals Carmell T2 Biosystems Bone Biologics Tivic Health Systems Acutus Medical (NASDAQ:AFIB) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings, valuation and community ranking. Do institutionals & insiders have more ownership in AFIB or NUWE? 56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 3.1% of Nuwellis shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 2.6% of Nuwellis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor AFIB or NUWE? Nuwellis received 10 more outperform votes than Acutus Medical when rated by MarketBeat users. Likewise, 53.66% of users gave Nuwellis an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote. CompanyUnderperformOutperformAcutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% NuwellisOutperform Votes2253.66% Underperform Votes1946.34% Which has more volatility & risk, AFIB or NUWE? Acutus Medical has a beta of -0.13, meaning that its share price is 113% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Is AFIB or NUWE more profitable? Nuwellis has a net margin of -169.54% compared to Acutus Medical's net margin of -272.74%. Acutus Medical's return on equity of -311.64% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Acutus Medical-272.74% -311.64% -11.57% Nuwellis -169.54%-28,159.25%-207.24% Does the media refer more to AFIB or NUWE? In the previous week, Nuwellis had 2 more articles in the media than Acutus Medical. MarketBeat recorded 2 mentions for Nuwellis and 0 mentions for Acutus Medical. Nuwellis' average media sentiment score of 0.72 beat Acutus Medical's score of 0.00 indicating that Nuwellis is being referred to more favorably in the news media. Company Overall Sentiment Acutus Medical Neutral Nuwellis Positive Do analysts rate AFIB or NUWE? Nuwellis has a consensus target price of $17.00, indicating a potential upside of 1,525.24%. Given Nuwellis' stronger consensus rating and higher probable upside, analysts plainly believe Nuwellis is more favorable than Acutus Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acutus Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nuwellis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has preferable earnings & valuation, AFIB or NUWE? Nuwellis has higher revenue and earnings than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcutus Medical$7.16M0.13-$81.66MN/AN/ANuwellis$8.74M0.52-$20.21M-$38.53-0.03 SummaryNuwellis beats Acutus Medical on 13 of the 17 factors compared between the two stocks. Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$953,000.00$4.34B$5.49B$7.95BDividend YieldN/A39.94%5.11%4.22%P/E RatioN/A30.6022.6218.58Price / Sales0.1355.28397.85103.49Price / CashN/A51.0838.1834.62Price / Book-1.076.066.744.25Net Income-$81.66M$68.71M$3.22B$248.18M7 Day PerformanceN/A-0.21%1.59%1.36%1 Month PerformanceN/A-2.36%4.09%3.85%1 Year PerformanceN/A22.30%15.98%5.37% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.03+3.9%N/A-79.5%$953,000.00$7.16M0.00340Gap DownHigh Trading VolumeNUWENuwellis3.0511 of 5 stars$0.89-4.5%$17.00+1,804.8%-81.7%$3.90M$8.74M-0.0170Upcoming EarningsShort Interest ↓VEROVenus Concept0.9021 of 5 stars$2.71-6.2%N/A-66.5%$3.86M$64.83M-0.34410CHEKCheck-Cap1.231 of 5 stars$0.65-3.4%N/A-65.4%$3.80MN/A-0.2280Short Interest ↓GCTKGlucoTrack1.8624 of 5 stars$0.14-12.3%N/A-99.7%$3.57MN/A0.005Short Interest ↓Gap DownHSCSHeart Test Laboratories2.256 of 5 stars$3.20-3.0%$13.00+306.3%-62.0%$3.46M$14,700.00-0.4010Short Interest ↑News CoverageQNRXQuoin Pharmaceuticals0.636 of 5 stars$5.67+3.5%N/A-72.7%$3.34MN/A-1.404Upcoming EarningsShort Interest ↑News CoverageGap DownCTCXCarmellN/A$0.16-1.9%N/A-92.0%$3.27M$32,839.000.0014TTOOT2 BiosystemsN/A$0.12+10.8%$5.00+4,155.3%-96.6%$2.47M$7.68M0.00180Upcoming EarningsGap UpBBLGBone Biologics0.8955 of 5 stars$0.69+1.5%N/A-56.9%$2.26MN/A0.002Positive NewsTIVCTivic Health Systems0.1807 of 5 stars$3.50flatN/A-75.3%$2.15M$780,000.000.0010Short Interest ↑Gap Down Related Companies and Tools Related Companies NUWE Competitors VERO Competitors CHEK Competitors GCTK Competitors HSCS Competitors QNRX Competitors CTCX Competitors TTOO Competitors BBLG Competitors TIVC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFIB) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AFIB Stock Free AFIB Stock Alerts